{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T07:07:10Z","timestamp":1763536030455,"version":"3.41.2"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>As chronic conditions, rare and complex connective tissue and musculoskeletal diseases (rCTDs) significantly affect the quality of life generating an impact on the physical, psychological, social, and economic dimensions of the patients\u2019 lives, having implications on the family, changing the lifestyle and interpersonal relationships. Traditionally, generic and disease-specific measures for Quality of Life (QoL) provide valuable information to clinicians since QoL affects healthcare services utilization, predicts morbidities and mortalities, workability, etc. Moreover, the assessment of unmet clinical needs, satisfaction, the experience with the treatment and the care, the psychological dimensions, and the effects of the diseases, such as fatigue, could represent valuable dimensions to be considered in the QoL impact assessment. It is also necessary to measure the impact of rCTDs by considering the perspectives of family members\/informal caregivers, for instance considering values, beliefs, experiences, life circumstances, psychological aspects, family relationships, economic issues, changes in social activities, etc.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>The aim of this scoping review is to better understand the status of QoL metrics used in clinical and economic research for the assessment of the individual\u2019s perspective on living with rCTDs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Research question<\/jats:title><jats:p>What are the main challenges in QoL measures (and\/or) measurement\/assessment in rCTDs?<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>Scoping review of the literature referring to QoL measures in rCTDs. Database: PUBMED, ISI-Web of Science; last date: 21\/09\/2021.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Anxiety and depression, body image satisfaction, daily activity, fatigue, illness perception, pain, personality, QoL, resilience, satisfaction with the relationship, self-management, sexual QoL, sleep quality, social support, stress, uncertainty, and work productivity are the observed dimensions covered by the included studies. However, \u201cmore shadows than lights\u201d can summarize the review\u2019s outcome in terms of Patient Reported Outcome Measures (PROMs) domains covered for each of the rCTDs. Also, for those diseases characterized by a relatively high prevalence and incidence, such as Systemic Lupus Erythematosus, Sj\u00f6gren\u2019s Syndrome, and Systemic Sclerosis, the analysis of patients\u2019 resilience, satisfaction with the quality of the relationship, personality, and stress are still missing dimensions. It has been observed how reducing items, increasing the number of domains, and disease-specific questionnaires characterize the \u201ctechnological trajectory,\u201d such as the evolution of questionnaires\u2019 characteristics for assessing QoL and QoL-related dimensions and the burden of rCTDs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The scoping review presents an overview of studies focused on questionnaires used to evaluate the different dimensions of quality of life in terms of general instruments and disease-specific questionnaires. Future research should include the co-design with patients, caregivers, and patient representatives to create questionnaires focused on the unmet needs of people living with rCTDs.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.986218","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T07:15:55Z","timestamp":1663917355000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["State of the art and future directions in assessing the quality of life in rare and complex connective tissue and musculoskeletal diseases"],"prefix":"10.3389","volume":"9","author":[{"given":"Leopoldo","family":"Trieste","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Cannizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Palla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isotta","family":"Triulzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Turchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.55563\/clinexprheumatol\/d2qz38","article-title":"The added value of a European reference network on rare and complex connective tissue and musculoskeletal diseases: Insights after the first 5 years of the ERN ReCONNET.","volume":"40","author":"Talarico","year":"2022","journal-title":"Clin Exp Rheumatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nrrheum.2016.137","article-title":"The global burden of SLE: Prevalence, health disparities and socioeconomic impact.","volume":"12","author":"Carter","year":"2016","journal-title":"Nat Rev Rheumatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e000794","DOI":"10.1136\/rmdopen-2018-000794","article-title":"Rare diseases under different levels of economic analysis: Current activities, challenges and perspectives.","volume":"4","author":"Cannizzo","year":"2018","journal-title":"RMD Open."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus.","volume":"365","author":"Tsokos","year":"2011","journal-title":"N Engl J Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e000469","DOI":"10.1136\/lupus-2020-000469","article-title":"Living with systemic lupus erythematosus in 2020: A European patient survey.","volume":"8","author":"Cornet","year":"2021","journal-title":"Lupus Sci Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"102691","DOI":"10.1016\/j.autrev.2020.102691","article-title":"Relationship between disease activity, organ damage and health-related quality of life in patients with systemic lupus erythematosus: A systemic review and meta-analysis.","volume":"20","author":"Shi","year":"2021","journal-title":"Autoimmun Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1177\/09612033211031008","article-title":"Cognitive impairment in systemic lupus erythematosus is negatively related to social role participation and quality of life: A systematic review.","volume":"30","author":"Mendelsohn","year":"2021","journal-title":"Lupus."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/art.24676","article-title":"Health-related quality of life in systemic sclerosis: A systematic review.","volume":"61","author":"Hudson","year":"2009","journal-title":"Arthritis Rheum."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.3390\/jcm10163754","article-title":"Patient-reported outcomes for quality of life in SLE: Essential in clinical trials and ready for routine care.","volume":"10","author":"Nguyen","year":"2021","journal-title":"J Clin Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.semarthrit.2016.02.005","article-title":"Impaired quality of life in systemic sclerosis and patient perception of the disease: A large international survey.","volume":"46","author":"Frantz","year":"2016","journal-title":"Semin Arthritis Rheum."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-32851-5","author":"Miedany","year":"2016","journal-title":"Patient reported outcome measures in rheumatic diseases."},{"key":"B12","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/rheumatology\/kes370","article-title":"Comparison of the psychometric properties of health-related quality of life measures used in adults with systemic lupus erythematosus: A review of the literature.","volume":"52","author":"Castelino","year":"2013","journal-title":"Rheumatology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1080\/1744666X.2018.1529566","article-title":"Factors affecting quality of life in patients with systemic lupus erythematosus: Important considerations and potential interventions.","volume":"14","author":"Elera-Fitzcarrald","year":"2018","journal-title":"Expert Rev Clin Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1097\/BOR.0000000000000416","article-title":"Socioeconomic consequences of systemic lupus erythematosus.","volume":"29","author":"Barber","year":"2017","journal-title":"Curr Opin Rheumatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/rheumatology\/kez300","article-title":"Health-related quality of life in systemic sclerosis before and after autologous haematopoietic stem cell transplant-a systematic review.","volume":"59","author":"Puyade","year":"2020","journal-title":"Rheumatology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e000373","DOI":"10.1136\/lupus-2019-000373","article-title":"Measurement properties of selected patient-reported outcome measures for use in randomised controlled trials in patients with systemic lupus erythematosus: A systematic review.","volume":"7","author":"Strand","year":"2020","journal-title":"Lupus Sci Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.semarthrit.2015.09.003","article-title":"Healthy lifestyle habits for patients with systemic lupus erythematosus: A systematic review.","volume":"45","author":"Rodr\u00edguez Huerta","year":"2016","journal-title":"Semin Arthritis Rheum."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.autrev.2015.07.012","article-title":"Quality of life in systemic sclerosis.","volume":"14","author":"Almeida","year":"2015","journal-title":"Autoimmun Rev."},{"key":"B19","first-page":"162","article-title":"Systemic sclerosis: Rehabilitation as a tool to cope with disability.","volume":"34","author":"Maddali-Bongi","year":"2016","journal-title":"Clin Exp Rheumatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.3899\/jrheum.151309","article-title":"Patients\u2019 perspectives and experiences living with systemic sclerosis: A systematic review and thematic synthesis of qualitative studies.","volume":"43","author":"Nakayama","year":"2016","journal-title":"J Rheumatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1111\/1756-185X.13438","article-title":"The impact of systemic sclerosis on health-related quality of life assessed by SF-36: A systematic review and meta-analysis.","volume":"21","author":"Li","year":"2018","journal-title":"Int J Rheum Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/jop.12739","article-title":"Impact of systemic sclerosis oral manifestations on patients\u2019 health-related quality of life: A systematic review.","volume":"47","author":"Smirani","year":"2018","journal-title":"J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1007\/s10067-021-05698-4","article-title":"Efficacy and safety of rituximab therapy in patients with systemic sclerosis disease (SSc): Systematic review and meta-analysis.","volume":"40","author":"Moradzadeh","year":"2021","journal-title":"Clin Rheumatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.autrev.2017.09.010","article-title":"Humanistic and cost burden of systemic sclerosis: A review of the literature.","volume":"16","author":"Fischer","year":"2017","journal-title":"Autoimmun Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.rdc.2020.07.004","article-title":"Socioeconomic status, health care, and outcomes in systemic lupus erythematosus.","volume":"46","author":"DeQuattro","year":"2020","journal-title":"Rheum Dis Clin North Am."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/PROM.S134326","article-title":"Impact of belimumab on patient-reported outcomes in systemic lupus erythematosus: Review of clinical studies.","volume":"10","author":"Bangert","year":"2019","journal-title":"Patient Relat Outcome Meas."},{"key":"B27","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1080\/13548506.2019.1587479","article-title":"The impact of systemic lupus erythematosus on health-related quality of life assessed using the SF-36: A systematic review and meta-analysis.","volume":"24","author":"Wang","year":"2019","journal-title":"Psychol Health Med."},{"key":"B28","first-page":"S150","article-title":"Fatigue in systemic sclerosis: A systematic review.","volume":"36","author":"Basta","year":"2018","journal-title":"Clin Exp Rheumatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/children7090146","article-title":"Pain symptomatology and management in pediatric ehlers-danlos syndrome: A review.","volume":"7","author":"Feldman","year":"2020","journal-title":"Child."},{"key":"B30","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/ajmg.c.31950","article-title":"Pain in the ehlers-danlos syndromes: Mechanisms, models, and challenges.","volume":"187","author":"Malfait","year":"2021","journal-title":"Am J Med Genet C Semin Med Genet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s11655-020-3473-0","article-title":"Focus on effects of chinese medicine on improving anxiety-depression and quality of life of patients with primary sj\u00f6gren\u2019s syndrome.","volume":"26","author":"Wu","year":"2020","journal-title":"Chin J Integr Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e0160753","DOI":"10.1371\/journal.pone.0160753","article-title":"Health-related quality of life (HRQoL) in idiopathic inflammatory myopathy: A systematic review.","volume":"11","author":"Leclair","year":"2016","journal-title":"PLoS One."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1177\/0961203320947802","article-title":"Cosmetic camouflage improves health-related quality of life in women with systemic lupus erythematosus and permanent skin damage: A controlled intervention study.","volume":"29","author":"Oliveira","year":"2020","journal-title":"Lupus."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s00296-018-4017-1","article-title":"Living with systemic lupus erythematosus in the developing world.","volume":"38","author":"Phuti","year":"2018","journal-title":"Rheumatol Int."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1093\/rheumatology\/keab847","article-title":"Healthcare utilization and economic burden in systemic sclerosis: A systematic review.","volume":"61","author":"Martin Calderon","year":"2021","journal-title":"Rheumatology."},{"key":"B36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1472-6947-7-16","article-title":"Utilization of the PICO framework to improve searching PubMed for clinical questions.","volume":"7","author":"Schardt","year":"2007","journal-title":"BMC Med Inform Decis Mak."},{"key":"B37","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e11376","DOI":"10.1097\/MD.0000000000011376","article-title":"Depression and anxiety in systemic lupus erythematosus: The crosstalk between immunological, clinical, and psychosocial factors.","volume":"97","author":"Figueiredo-Braga","year":"2018","journal-title":"Medicine."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.3899\/jrheum.141482","article-title":"Evaluation of the satisfaction with appearance scale and its short form in systemic sclerosis: Analysis from the UCLA scleroderma quality of life study.","volume":"42","author":"Mills","year":"2015","journal-title":"J Rheumatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e0210466","DOI":"10.1371\/journal.pone.0210466","article-title":"Personality, depression and anxiety in primary Sjogren\u2019s syndrome - Association with sociodemographic factors and comorbidity.","volume":"14","author":"Milic","year":"2019","journal-title":"PLoS One."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s10067-019-04898-3","article-title":"The impacts of resilience on the association between illness uncertainty and sleep quality among Chinese women with systemic lupus erythematosus.","volume":"39","author":"Li","year":"2020","journal-title":"Clin Rheumatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1080\/03009742.2021.1917142","article-title":"Validity and reliability of the Swedish version of the self-efficacy for managing chronic disease scale for individuals with systemic sclerosis.","volume":"51","author":"Mattsson","year":"2022","journal-title":"Scand J Rheumatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10067-017-3743-1","article-title":"Relatives\u2019 quality of life and psychological disturbance: A new concern of SLE management.","volume":"37","author":"Zeng","year":"2018","journal-title":"Clin Rheumatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1177\/0961203317749746","article-title":"Individuals living with lupus: Findings from the LUPUS UK members survey 2014.","volume":"27","author":"Morgan","year":"2018","journal-title":"Lupus."},{"key":"B45","doi-asserted-by":"publisher","first-page":"194","DOI":"10.36628\/ijhf.2021.0026","article-title":"Using big data to understand rare diseases.","volume":"3","author":"Park","year":"2021","journal-title":"Int J Hear Fail."},{"key":"B46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13075-021-02430-0","article-title":"Which patient-reported outcomes do rheumatology patients find important to track digitally? A real-world longitudinal study in arthritis power.","volume":"23","author":"Nowell","year":"2021","journal-title":"Arthritis Res Ther."},{"key":"B47","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.semarthrit.2014.05.013","article-title":"Autonomic symptom burden in the hypermobility type of Ehlers-Danlos syndrome: a comparative study with two other EDS types, fibromyalgia, and healthy controls.","volume":"44","author":"De Wandele","year":"2014","journal-title":"Semin Arthritis Rheum."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e00586","DOI":"10.1002\/brb3.586","article-title":"Cognition, depression, fatigue, and quality of life in primary Sj\u00f6gren\u2019s syndrome: correlations.","volume":"6","author":"Ko\u00e7er","year":"2016","journal-title":"Brain Behav."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1007\/s00296-013-2680-9","article-title":"Sleep quality in patients with systemic sclerosis: relationship between the clinical variables, depressive symptoms, functional status, and the quality of life.","volume":"33","author":"Sariyildiz","year":"2013","journal-title":"Rheumatol Int."},{"key":"B50","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1756-185X.2011.01698.x","article-title":"The impact of obesity in systemic lupus erythematosus on disease parameters, quality of life, functional capacity and the risk of atherosclerosis.","volume":"15","author":"Rizk","year":"2012","journal-title":"Int J Rheum Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.chest.2016.11.052","article-title":"Improved cough and cough-specific quality of life in patients treated for scleroderma-related interstitial lung disease: results of scleroderma lung study II.","volume":"151","author":"Tashkin","year":"2017","journal-title":"Chest."},{"key":"B52","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3899\/jrheum.191375","article-title":"The effect of creatine supplementation on muscle function in childhood myositis: a randomized, double-blind, placebo-controlled feasibility study.","volume":"48","author":"Dover","year":"2021","journal-title":"J Rheumatol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.rdc.2016.01.001","article-title":"Patient-reported outcomes in systemic lupus erythematosus.","volume":"42","author":"Mahieu","year":"2016","journal-title":"Rheum Dis Clin North Am."},{"key":"B54","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/0961203318817826","article-title":"Fatigue in systemic lupus: the role of disease activity and its correlates.","volume":"28","author":"Azizoddin","year":"2019","journal-title":"Lupus."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.3899\/jrheum.141475","article-title":"Quality of sexual life in women with primary sj\u00f6gren syndrome.","volume":"42","author":"Priori","year":"2015","journal-title":"J Rheumatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1177\/0961203317751858","article-title":"Illness perception is significantly determined by depression and anxiety in systemic lupus erythematosus.","volume":"27","author":"Nowicka-Sauer","year":"2018","journal-title":"Lupus."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e0244959","DOI":"10.1371\/journal.pone.0244959","article-title":"Functioning in adult patients with idiopathic inflammatory myopathy: Exploring the role of environmental factors using focus groups.","volume":"16","author":"Armadans-Tremolosa","year":"2021","journal-title":"PLoS One."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3899\/jrheum.200733","article-title":"National sj\u00f6gren\u2019s foundation survey: burden of oral and systemic involvement on quality of life.","volume":"48","author":"McCoy","year":"2021","journal-title":"J Rheumatol."},{"key":"B59","first-page":"S53","article-title":"Determinants of health-related quality of life in a multinational systemic sclerosis inception cohort.","volume":"36","author":"Morrisroe","year":"2018","journal-title":"Clin Exp Rheumatol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1002\/ajmg.a.40371","article-title":"Pain and sleep quality in children with non-vascular ehlers-danlos syndromes.","volume":"176","author":"Muriello","year":"2018","journal-title":"Am J Med Genet A."},{"key":"B61","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/acr.22650","article-title":"Pain, fatigue, and psychological impact on health-related quality of life in childhood-onset lupus.","volume":"68","author":"Jones","year":"2016","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"B62","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1159\/000493480","article-title":"Comparison of pain characteristics in patients with rheumatoid arthritis and systemic sclerosis with particular reference to the neuropathic pain component: cross-sectional study.","volume":"27","author":"Cengiz","year":"2018","journal-title":"Med Princ Pract Int J Kuwait Univ Heal Sci Cent."},{"key":"B63","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/0091217415582183","article-title":"Quality of life in rheumatological patients: the impact of personality disorders.","volume":"49","author":"Uguz","year":"2015","journal-title":"Int J Psychiatry Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1177\/0961203315580871","article-title":"Impairment of quality of life in patients with antiphospholipid syndrome.","volume":"24","author":"Zuily","year":"2015","journal-title":"Lupus."},{"key":"B65","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10067-016-3471-y","article-title":"Health-related quality of life and utility: comparison of ankylosing spondylitis, rheumatoid arthritis, and systemic lupus erythematosus patients in Taiwan.","volume":"36","author":"Chen","year":"2017","journal-title":"Clin Rheumatol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1177\/09612033211016098","article-title":"Clinical characteristics of itch in cutaneous lupus erythematosus: a prospective, multicenter, multinational, cross-sectional study.","volume":"30","author":"Samotij","year":"2021","journal-title":"Lupus."},{"key":"B67","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/1756-185X.14120","article-title":"Health-related quality of life and work impairment in idiopathic inflammatory myopathies in South Australia.","volume":"24","author":"Xu","year":"2021","journal-title":"Int J Rheum Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"108392","DOI":"10.1016\/j.clim.2020.108392","article-title":"Health-related quality of life in patients with immune mediated inflammatory diseases: a cross-sectional, multidisciplinary study.","volume":"214","author":"Spierings","year":"2020","journal-title":"Clin Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e28124","DOI":"10.2196\/28124","article-title":"Smartphone-assisted high-intensity interval training in inflammatory rheumatic disease patients: randomized controlled trial.","volume":"9","author":"Haglo","year":"2021","journal-title":"JMIR Mhealth Uhealth."},{"key":"B70","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1177\/0961203317717082","article-title":"Disease-specific quality of life in patients with lupus nephritis.","volume":"27","author":"Jolly","year":"2018","journal-title":"Lupus."},{"key":"B71","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/0961203316659546","article-title":"Relationship between health-related quality of life, disease activity and disease damage in a prospective international multicenter cohort of childhood onset systemic lupus erythematosus patients.","volume":"26","author":"Moorthy","year":"2017","journal-title":"Lupus."},{"key":"B72","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1177\/0961203317717631","article-title":"Health status and concomitant prescription of immunosuppressants are risk factors for hydroxychloroquine non-adherence in systemic lupus patients with prolonged inactive disease.","volume":"27","author":"Iudici","year":"2018","journal-title":"Lupus."},{"key":"B73","doi-asserted-by":"publisher","first-page":"5060","DOI":"10.1093\/rheumatology\/keab397","article-title":"Sexual function in patients with idiopathic inflammatory myopathies: a cross-sectional study.","volume":"60","author":"He\u00f8m\u00e1nkov\u00e1","year":"2021","journal-title":"Rheumatology (Oxford)."},{"key":"B74","doi-asserted-by":"publisher","first-page":"623","DOI":"10.5664\/jcsm.7058","article-title":"Sleep disorders and their management in children with ehlers-danlos syndrome referred to sleep clinics.","volume":"14","author":"Domany","year":"2018","journal-title":"J Clin sleep Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/1756-185X.12418","article-title":"Sleep quality in women with systemic lupus erythematosus: contributing factors and effects on health-related quality of life.","volume":"19","author":"Mirbagher","year":"2016","journal-title":"Int J Rheum Dis."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.3904\/kjim.2017.158","article-title":"Impact of sleep quality on clinical features of primary Sj\u00f6gren\u2019s syndrome.","volume":"34","author":"Chung","year":"2019","journal-title":"Korean J Intern Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1177\/0961203320983445","article-title":"Delayed diagnosis adversely affects outcome in systemic lupus erythematosus: cross sectional analysis of the LuLa cohort.","volume":"30","author":"Kernder","year":"2021","journal-title":"Lupus."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnbeh.2018.00225","article-title":"Frontal. EEG asymmetry and middle line power difference in discrete emotions.","volume":"12","author":"Zhao","year":"2018","journal-title":"Front Behav Neurosci."},{"key":"B79","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/rheumatology\/keab324","article-title":"Relevant domains and outcome measurement instruments in neuropsychiatric systemic lupus erythematosus: A systematic literature review.","volume":"61","author":"Silvagni","year":"2022","journal-title":"Rheumatology."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.986218\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T07:16:03Z","timestamp":1663917363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.986218\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":79,"alternative-id":["10.3389\/fmed.2022.986218"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.986218","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"article-number":"986218"}}